Active Infection & Immunity Public Health & Healthcare

Wellcome Centre for Infectious Diseases Research in Africa Discovery Platforms in Science

In plain English

AI plain-English summary

A South African research centre is expanding its clinical, laboratory, and data-analysis platforms to fight HIV-1, tuberculosis, and COVID-19 more effectively. The Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) already runs three platforms—clinical science, basic science, and data integration—that support investigator-led research. This grant sustains and strengthens those platforms with new staff and equipment. The clinical platform will add a senior nurse dedicated to pharmacokinetic/pharmacodynamic studies and a part-time pharmacometrician, enabling more rational use of existing and repurposed anti-infectives and vaccines. The basic science platform will expand access to world-class imaging facilities for single-cell technologies. The data platform will increase end-to-end bioinformatic services and help researchers use the Public Health Data Centre, a continentally unique consolidated environment for person-level health data. If successful, this work will improve how anti-infective drugs and vaccines are tested and deployed in Africa, where the burden of these diseases is highest. It will also build a skilled workforce and technical infrastructure that can respond to future outbreaks. The data platform, in particular, could transform how public health data is shared and analysed across the continent, strengthening the systems that quietly underpin disease surveillance and treatment decisions.

View original technical description
The Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1, tuberculosis (TB) and lower respiratory infections including COVID-19. The centre is already organised into three platforms supporting Clinical Science, Basic Science and Data integration. This application will strategically build on, and sustain, the success of these platforms by providing skilled human and state-of-the-art technical resources. Specifically 1. The clinical platform will strengthen capacity to investigate more rational use of existing, repurposed and new anti-infectives and vaccines by supporting its facilities to provide imaging, regulatory compliance, data capture and analysis and on site laboratory capability. In particular the pharmacokinetic and pharmacodynamic (PK/PD) analyses will be improved by appointment of senior nurse dedicated to PK/PD studies and by the part-time appointment of a pharmacometrician. 2. The Basic Science will expand access and training in existing world-class imaging facilities to provide project specific solutions and expertise to projects that require single cell technologies. 3. The Data integration platform will increase availability of end-to-end bioinformatic services and also increase the ability of researchers to harness the Public Health Data Centre: a continentally unique single consolidated environment for person-level health data.

View the original record at the funder ↗

Researchers

Andrew Boulle (EPMC Awardee)Digby Warner (EPMC Awardee)Elisa Nemes (EPMC Awardee)Hannah Hussey (EPMC Awardee)Molebogeng Rangaka (EPMC Awardee)Nicola Mulder (EPMC Awardee)Robert Wilkinson (EPMC Awardee)Sean Wasserman (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Centre for Infectious Diseases Research in Africa (CIDRI-Africa)
Establishment of a Centre for Clinical Infectious Diseases Research at the University of Cape Town (Wellcome-UCT-CCIDR).
MRC Centre for Global Infectious Disease Analysis (MRC GIDA)
Preparedness, Research and Surveillance Network for infectious Diseases in Central Africa
CATCR: Central Africa Training Platform for Clinical Research on infectious diseases

Original classification

Directed Call

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.